These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6125087)

  • 1. The effect of adrenergic blockade on the insulin release after intraduodenal glucose in man.
    Flaten O; Sand T; Myren J
    Acta Physiol Scand; 1981; 113(3):415-6. PubMed ID: 6125087
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adrenoceptor blockade on the release of gastric inhibitory polypeptide after intraduodenal glucose in humans.
    Flaten O
    Scand J Gastroenterol; 1981; 16(5):641-5. PubMed ID: 7323697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
    Flaten O; Sand T; Myren J
    Scand J Gastroenterol; 1982 Mar; 17(2):283-8. PubMed ID: 6127792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic modulation of the release of pancreatic polypeptide after intraduodenal and oral glucose in man.
    Flaten O; Myren J
    Scand J Gastroenterol; 1981; 16(6):781-7. PubMed ID: 6275494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 7. A mechanism for regulation of insulin release in hypoxia.
    Baum D; Porte D
    Am J Physiol; 1972 Mar; 222(3):695-9. PubMed ID: 4401851
    [No Abstract]   [Full Text] [Related]  

  • 8. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats.
    Andersson PO; Holst J; Järhult J
    Acta Physiol Scand; 1982 Dec; 116(4):403-9. PubMed ID: 6133409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man.
    Thomas FB; Sinar D; Mazzaferri EL; Cataland S; Mekhjian HS; Caldwell JH; Fromkes JJ
    Gastroenterology; 1978 Jun; 74(6):1261-5. PubMed ID: 648819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-induced gastric inhibitory polypeptide secretion in man.
    LeRoith D; Spitz IM; Ebert R; Liel Y; Odes S; Creutzfeldt W
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1385-9. PubMed ID: 7002949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha and beta adrenergic blockade on hepatic glucose balance before and after oral glucose. Role of insulin and glucagon.
    Chap Z; Ishida T; Chou J; Michael L; Hartley C; Entman M; Field JB
    J Clin Invest; 1986 Apr; 77(4):1357-69. PubMed ID: 2870078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
    Ebert R; Illmer K; Creutzfeldt W
    Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraduodenal osmolality directly enhances insulin secretion in the rat.
    Ikeda T; Ishimura M; Terasawa H; Ochi H; Fujiyama K; Hoshino T; Tanaka Y; Mashiba H
    Life Sci; 1992; 51(17):PL153-7. PubMed ID: 1357519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
    Saitta A; Quartarone M; Cucinotta D; Mangano C; Pizzoleo MA; Squadrito G
    Minerva Med; 1979 May; 70(22):1611-5. PubMed ID: 36579
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric inhibitory polypeptide: physiology and novel aspects.
    Flaten O
    Scand J Gastroenterol; 1983 Jan; 18(1):1-4. PubMed ID: 6144168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of the metabolic and circulatory (cardiovascular) effects of diazoxide through alpha--and beta-receptor blockade].
    Börner E; Biro G; Kettl H; Weinges KF
    Horm Metab Res; 1969 Nov; 1(6):296-300. PubMed ID: 4401003
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.